News & Updates
Filter by Specialty:
Canagliflozin blunts end-stage renal disease risk in T2DM patients with CKD
11 Aug 2022
In patients with type 2 diabetes mellitus (T2DM) with chronic kidney disease (CKD), treatment with canagliflozin safely decreases the risk of developing end-stage renal disease, reports a new Japan study.
Canagliflozin blunts end-stage renal disease risk in T2DM patients with CKD
11 Aug 2022
1 week off methotrexate works okay for RA patients receiving flu shot
11 Aug 2022
Temporarily discontinuing methotrexate treatment for 1 week appears to induce satisfactory response to a seasonal influenza vaccine in patients with rheumatoid arthritis (RA), with a similar effect as a 2-week interruption schedule, according to a study.
1 week off methotrexate works okay for RA patients receiving flu shot
11 Aug 2022
High vitamin B6 status tied to better survival in stage I–III colorectal cancer
10 Aug 2022
Higher preoperative vitamin B6 status appears to improve the overall survival (OS) of patients with stage I‒III colorectal cancer (CRC), suggests a recent study.
